Parkinson's disease Symptoms Before and After Levodopa-Carbidopa Intestinal Gel: a Subanalysis From the COSMOS Study

被引：0
|
作者：
Fasano, A. [1 ]
Toomsoo, T. [2 ]
Hassin-Baer, S.
Van Kesteren, M.
Parra, J. [3 ]
Femia, S.
Chico, S.
Alobaidi, A.
Szasz, J.
机构：
[1] Div Neurol, Toronto, ON, Canada
[2] Dept Neurol, Tallinn, Estonia
[3] AbbVie Inc, N Chicago, IL USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
OPR-150
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [31] The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England
    K. Ray Chaudhuri
    A. Simon Pickard
    Ali Alobaidi
    Yash J. Jalundhwala
    Prasanna L. Kandukuri
    Yanjun Bao
    Julia Sus
    Glynn Jones
    Christian Ridley
    Julia Oddsdottir
    Seyavash Najle-Rahim
    Matthew Madin-Warburton
    Weiwei Xu
    Anette Schrag
    PharmacoEconomics, 2022, 40 : 559 - 574
  • [32] Advanced Parkinson's Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis
    Simu, Mihaela Adriana
    Jianu, Dragos Catalin
    Dulamea, Adriana Octaviana
    Constantin, Viorelia Adelina
    Popescu, Diana
    Parra, Juan Carlos
    Szasz, Jozsef Attila
    BRAIN SCIENCES, 2021, 11 (12)
  • [33] Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations
    Balestrino, R.
    Martone, T.
    Toffoli, M.
    Montanaro, E.
    Fabbri, M.
    Artusi, C. A.
    Romagnolo, A.
    Zibetti, M.
    Rizzone, M.
    Goldwurm, S.
    Lopiano, L.
    Schapira, A. H. V.
    NEUROLOGICAL SCIENCES, 2024, 45 (04) : 1489 - 1497
  • [34] Comprehensive assessment of levodopa-carbidopa intestinal gel for Turkish advanced Parkinson's disease patients
    Karadag, Yesim Sucullu
    Saltoglu, Tugce
    Kucukdagli, Fadime Erdogan
    Ozturk, Omer
    Koseoglu, Tankut
    Altiparmak, Emin
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (01) : 84 - 89
  • [35] Does levodopa-carbidopa intestinal gel in Parkinson's disease patients increase the risk on polyneuropathy?
    Moes, H.
    Drent, M.
    Laar, T.
    MOVEMENT DISORDERS, 2017, 32
  • [36] Levodopa-carbidopa intestinal gel is an option in Parkinson’s disease with hyponatremia induced by dopamine agonists
    Marina Picillo
    Vincenzo Canoro
    Giulio Cicarelli
    Roberto Erro
    Paolo Barone
    Neurological Sciences, 2020, 41 : 3361 - 3363
  • [37] Reply to Letter: Suicide in Parkinson's Disease Patients Treated With Levodopa-Carbidopa Intestinal Gel
    Fernandez, Hubert H.
    Standaert, David G.
    Chatamra, Krai
    Benesh, Janet A.
    MOVEMENT DISORDERS, 2015, 30 (10) : 1435 - 1436
  • [38] Levodopa-carbidopa intestinal gel is an option in Parkinson's disease with hyponatremia induced by dopamine agonists
    Picillo, Marina
    Canoro, Vincenzo
    Cicarelli, Giulio
    Erro, Roberto
    Barone, Paolo
    NEUROLOGICAL SCIENCES, 2020, 41 (11) : 3361 - 3363
  • [39] Effect of levodopa-carbidopa intestinal gel on resting tremor in patients with advanced Parkinson's disease
    Fernandez, H. H.
    Dubow, J.
    Robieson, W. Z.
    Chatamra, K.
    Eaton, S.
    Benesh, J. A.
    Odin, P.
    MOVEMENT DISORDERS, 2015, 30 : S84 - S85
  • [40] Long-Term Safety of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
    Rodriguez, Ramon L.
    Schmulewitz, Nathan
    Hall, Coleen
    Eaton, Susan
    Dubow, Jordan
    Benesh, Janet
    ANNALS OF NEUROLOGY, 2014, 76 : S46 - S46
12345